Fun speculation.

My POV is that neither company has an approved drug. Also, I sense that BPs are very concervative. So my perspective is that one or more BPs may be interested but at what price at this stage. Don has fought hard for many years and he fully understands the potential held in both companies. He will not let that slip away at a low price. Nor will Eastern let that happen. Also, at this stage it would be difficult to put a value on each company, none the less the combined companies. I am sure that the BPs understand the market value of the 2 test drugs. Applying a probability of success fo each drug and applying some cost and pricing scenarios would provide a reference system. Plus, there is the value of the IP.

I speculate we are not yet at a buyout stage but i do believe there is some sort of Hepa deal being worked out. The challenge is that it needs to be a $120,000,000 plus deal.

Just some thoughts.

GLTA

Toinv